Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection Conducted for Sawston, UK Facility

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Related Keywords

Sawston ,Cambridgeshire ,United Kingdom ,United States ,America ,Les Goldman ,Dave Innes ,Exchange Commission ,Company Securities ,United Kingdom Human Tissue Authority ,University Of Pennsylvania ,Health Products Regulatory Authority ,United Kingdom Medicines ,North America ,Private Securities Litigation Reform Act ,Risk Factors ,Northwest Biotherapeutics ,